Amgen News and Activities

Presence

Amgen develops and sells medicines for serious diseases. Its products include biologic therapies and related services for hospitals, clinics, and patients in areas such as cancer, inflammation, bone health, and rare conditions.

Amgen products and services overview:

Biologic medicines
Cancer treatments
Inflammation therapies
Bone health drugs
Rare disease therapies
Biosimilar medicines

Revenue: ~$33 billion

Employees: 28,000

Headquarters: Thousand Oaks, United States (USA)

Amgen is one of the...

Amgen is a company listed under the stock ticker AMGN (US).

Amgen has a direct presence in 22 countries.

Amgen has 26 subsidiaries including Amgen APAC, Amgen Argentina and Amgen Australia.

They are in:

Pharmaceuticals78%
Biotechnology22%

Acquisition, funding and merger involving Amgen.

Amgen has acquired Dark Blue Therapeutics (posted on January 7 2026).

Executives

View the org chart displaying its 247 main executives

Most searched biographies at Amgen

Popular executive movements at Amgen

Thomas Dittrich has joined the company as Chief Financial Officer (posted on May 20 2026).
Peter Griffith, Executive Vice President and Chief Financial Officer, will leave the company on Sep. 1, 2026 (posted on May 20 2026).
David Reese, Executive Vice President and Chief Technology Officer, will leave the company on Jun. 30, 2026 (posted on April 23 2026).

Click here to view some more movements at Amgen

Create your alert
to follow the executive moves at Amgen.